LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza

News - Research use only reagents allows detection of SARS-CoV-2, influenza A, and influenza B from a single patient sample

02 February 2021

LGC’s high-throughput PCR testing system for SARS-CoV-2 detection granted Emergency Use Authorisation

News - Authorisation enables qualified laboratories to address SARS-CoV-2 testing demands while providing significant economic advantage when compared to other technologies

20 April 2021

LGC’s ultra-high throughput Nexar™ technology provides significant PCR testing capacity at Rosalind Franklin Laboratory

News - Ultra-high throughput technology enables large-scale PCR testing in reposnse to global pandemic

13 July 2021

LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

29 October 2021